Skip to main content
Caplight Logo









CellMax Life

CellMax Life

Private
Sunnyvale, CaliforniaHealthcare & Life Scienceshttps://cellmaxlife.com/

Last Round

Series C

Mar 23, 2021

Est. Valuation

$14M

Total Funding Raised

$9.76M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

CellMax Life is a biotechnology company that develops non-invasive blood tests for early cancer detection and screening.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

liquid biopsyCTCcirculating tumor cellscancer diagnosticscancer screeningnon-invasive screeningmolecular diagnosticsearly cancer detectionmicrofluidicshereditary cancer screeningprecision medicineblood-based cancer testclinical laboratoryCLIA-certified labgenomic analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CellMax Life Comparables

Compare CellMax Life with similar companies based on industry and business-model similarity.

CellMax Life comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Epic Sciences
81%
Datar Cancer Genetics
81%
DiaCarta, Inc.
80%

CellMax Life Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 23, 2021
GrantJun 14, 2017
Series A ExtensionJul 26, 2016

Key People

Founding team and executive leadership

Atul Sharan

President & CEO

Executive Team

CellMax Life Investors

Notable investors and investment history

CellMax Life investors
InvestorRounds
Aflac VenturesSeries C
ArtimanSeries C, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 45% MoM, from 1.2K to 1.8K.

  • Jul 26, 2016

    $9M round led by Artiman

CellMax Life Filings

Explore SEC and related filing metadata, where available.

CellMax Life filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CellMax Life's valuation, stock price, and market status.

Is CellMax Life a public or private company?

CellMax Life is a private company.

What is the current stock price of CellMax Life?

CellMax Life is a private company with no public stock price. No recent secondary market data is available.

How much is CellMax Life worth (valuation)?

Valuation information for CellMax Life is not publicly available.

Can I buy CellMax Life stock?

CellMax Life shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CellMax Life's last funding round?

CellMax Life's most recent funding round was Series C on March 23, 2021.

Who are the main investors in CellMax Life?

Key investors in CellMax Life include Aflac Ventures.

Will CellMax Life IPO soon?

No public IPO plans have been announced for CellMax Life.

How can I track CellMax Life secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CellMax Life's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSunnyvale, California
Employee Range27
Year Founded2012
Last FundingMar 23, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?